Search Results 121-130 of 818 for ���������������������������������������������:PC90���

  1. A Study to Evaluate Precision Pharmacogenomics in Cancer Patients - Mayo Clinic

    THe purpose of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a cohort of cancer ...

  2. A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease - Mayo Clinic

    The primary objective is to evaluate whether macitentan 10 mg reduces N-terminal pro-brain natriuretic peptide (NT-pro-BNP) as compared to placebo in these ...

  3. The DIAGNOSE CTE Research Project-II - Mayo Clinic

    The purpose of this study aims to retain and grow DIAGNOSE-I and examine the clinical and biomarker course of TES; investigate risk and resilience factors of ...

  4. Individualized Temozolomide in Treating Patients with Stage IV Melanoma that Cannot be Removed by Surgery - Mayo Clinic

    This clinical trial studies individualized temozolomide (TMZ) in treating patients with stage IV melanoma that cannot be removed by surgery. Drugs used in ...

  5. A Study to Evaluate Posoleucel ALVR105 to Treat Kidney Transplant Recipients with BK Viremia - Mayo Clinic

    The key secondary objective is to test the hypothesis that the administration of posoleucel ALVR105 to kidney transplant recipients with BK viremia will ...

  6. A Study of the Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) - Mayo Clinic

    About this study. The purpose of this study is to demonstrate the superiority of MD1003 (300 mg/day) over placebo to clinically improve patients with ...

  7. Study to Evaluate Eradicating Barrett's Esophagus Using Radiofrequency Ablation or a Novel Hybrid Argon Plasma Coagulation Technique - Mayo Clinic

    About this study. The purpose of this study is to investigate if Hybrid Argon Plasma Coagulation (HAPC) is non-inferior to Radiofrequency Ablation (RFA) in ...

  8. A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301) - Mayo Clinic

    The purpose of this study is to compare ipilimumab with and without IMO-2125 in advanced melanoma patients. Participation eligibility. Participant eligibility ...

  9. Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial - Mayo Clinic

    A transient ischemic attack (TIA) is a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia, without acute ...

  10. A Study to Collect, Process, and Grow New Bone Cells from Human Pericranium - Mayo Clinic

    Can pericranium be used to regrow bone for the repair of critical mandibular defects? Participation eligibility. Participant eligibility includes age, gender, ...